Kaplan-Meier survival analysis revealed that high expression levels of HSP90AA1, HSP90AB1, and SRC were associated with poor prognosis in HCC patients (p < 0.05), highlighting their potential as prognostic biomarkers (Figure 5D). Here, HSP90AA1 is linked to hepatocellular carcinoma.